152402-98-7 Usage
Uses
Used in Pharmaceutical Industry:
2-[[(4-Nitro-3-Methyl-2-Pyridinyl)-2-Methyl]Thio]-1H-Benzimidazole is used as a potential anti-tumor agent for its therapeutic effects in cancer treatment. Its complex structure and molecular features contribute to its potential as a promising candidate in the development of new cancer therapies.
Used in Organic Synthesis:
In the field of organic chemistry, 2-[[(4-Nitro-3-Methyl-2-Pyridinyl)-2-Methyl]Thio]-1H-Benzimidazole serves as a building block in the synthesis of other organic compounds. Its unique structure allows for the creation of a variety of new molecules with potential applications in various industries, including pharmaceuticals, materials science, and agrochemicals.
Used in Medicinal Research:
The molecular features of 2-[[(4-Nitro-3-Methyl-2-Pyridinyl)-2-Methyl]Thio]-1H-Benzimidazole make it a valuable tool in medicinal research. It can be used to study the mechanisms of action of various drugs, develop new drug candidates, and explore the potential of novel therapeutic approaches in treating diseases, particularly cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 152402-98-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,4,0 and 2 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 152402-98:
(8*1)+(7*5)+(6*2)+(5*4)+(4*0)+(3*2)+(2*9)+(1*8)=107
107 % 10 = 7
So 152402-98-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H12N4O2S/c1-9-12(15-7-6-13(9)18(19)20)8-21-14-16-10-4-2-3-5-11(10)17-14/h2-7H,8H2,1H3,(H,16,17)
152402-98-7Relevant academic research and scientific papers
Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties
-
Page/Page column 45, (2008/06/13)
Chemical syntheses and medical uses of novel inhibitors of the gastric H+, K+-ATPase for the treatment and/or management of duodenal ulcers, heartburn, acid reflux, other conditions mediated by gastric acid secretion and/or psoriasis are described.
Synthetic studies connected with the preparation of H+/K +-ATPase inhibitors rabeprazole and lansoprazole
Radl, Stanislav,Klecan, Ondrej,Havlicek, Jaroslav
, p. 1447 - 1453 (2007/10/03)
Synthesis of lansoprazole and rabeprazole using common intermediates is devised. The common intermediates, 2-[(4-nitro-3-methylpyridin-2-yl) methanesulfanyl]-1H-benzoimidazole and 2-[(4-chloro-3-methyl-pyridin-2-yl) methanesulfanyl]-1H-benzoimidazole, were prepared in several ways.
